Clinical Studies Sweden
Clinical Studies Sweden is a collaboration between Sweden’s six healthcare regions, funded and supported by the Swedish Research Council. The collaboration aims to simplify and develop the work of clinical studies.
The six health and medical care regions take part in the collaboration via a collaboration function, a regional node.
The regional nodes collaborate with each other at national level by:
- proposing and running national development initiatives.
- day-to-day coordination and exchange of experiences of processes and support structures, such as study requests
- working together on issues and challenges relating to statistics and follow-up of clinical studies
- working together on communication issues linked to the Clinical Studies Sweden collaboration.
The nodes also work to strengthen the prerequisites for conducting clinical studies within the own region, by:
- capturing the development needs that may develop via the collaboration Clinical Studies Sweden, for example in a development initiative
- reaching out with results and support produced in development initiatives within Clinical Studies Sweden (länk utvecklingssatsningar)
- providing and further developing regional support and support structures.
The regional nodes provide:
- support to companies and researchers in study requests (investigate whether a study can be conducted in the region, so called feasibility)
- advice and support for clinical studies, from idea to archiving (such as study protocols, permit applications, data management and statistics)
- infrastructure for conducting clinical studies (such as FITH-Phase-IV and specialist units within primary care and paediatrics)
- training within clinical research methodology (such as GCP and statistics)
- contacts with experts in clinical studies (such as statistics, epidemiology, health economics)
- contact with regional resources (such as research units, quality register centres, biobanks, cancer centres).
Below follows a brief description of the structure of each node.